Sonali Setlore Biligiri, MD, is a board-certified endocrinologist and internal medicine physician. She currently serves as a Medical Director at Novo Nordisk, bringing a frontline clinician’s perspective to medical strategy and therapeutic development in metabolic and endocrine care. Her clinical work centers on comprehensive metabolic health and glucose management, thyroid and hormonal health, and bone and mineral metabolism. Her research interests include optimizing bone-density preservation strategies, endocrine genetics and adrenal steroid biology, and clinical development approaches that translate endocrine science into patient-centered therapies. Dr. Biligiri has been recognized as a Top Doctor in Endocrinology by Delaware Today and has presented clinical research at major international endocrine meetings, including conferences hosted by the Endocrine Society. She earned her MD from Drexel University College of Medicine, completed an internal medicine residency at Drexel University College of Medicine, and completed fellowship training in Endocrinology, Diabetes, and Metabolism.
Medical Director
Medical School
2011 – 2015
Residency
2015 – 2018
Fellowship
2018 – 2020